(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AVIDAS PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AVIDAS PHARMACEUTICALS

ST13

US500000077575716

Class

5

Filing

77575716

Registration

4283224

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

66

Latest update

01/06/2024

Trademark type

Combined

Nice classes

5

Filing date

09/22/2008

Registration date

01/29/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/06/2024

Last transaction

01/06/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/09/2009

First use in commerce

02/09/2009

Drawing code

3

Owner type

16

Owner location

Doylestown, PA, US

Examiner

BUONGIORNO, CHRISTOPHER

Law office

L20

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the word "AVIDAS" having a stylized letter "V" above three incomplete ovals; the word "PHARMACEUTICALS" appears beneath the letters "D","A","S" in the term "AVIDAS".

Holders and representatives

Holders

Avidas Pharmaceuticals LLC

Representatives

Keith R. Lange Lange IP Law

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for use in dermatology

Publications

History of USPTO decisions and trademark events.

66 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/06/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/06/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/06/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/06/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

07/10/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/29/2022

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

02/29/2020

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

02/29/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/11/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/11/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

02/11/2020

PRA8

POST REGISTRATION ACTION MAILED - SEC. 8

08/12/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/12/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/29/2019

ES8R

TEAS SECTION 8 RECEIVED

07/29/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/29/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

01/29/2013

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/25/2012

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

12/22/2012

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/17/2012

XAEC

EXAMINER'S AMENDMENT ENTERED

12/17/2012

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/17/2012

GNEA

EXAMINERS AMENDMENT E-MAILED

12/17/2012

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

12/17/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/06/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/06/2012

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

12/03/2012

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

06/04/2012

GNFR

FINAL REFUSAL E-MAILED

06/04/2012

CNFR

SU - FINAL REFUSAL - WRITTEN

06/04/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/02/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/02/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/25/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/19/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/19/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/25/2011

GNRT

NON-FINAL ACTION E-MAILED

10/25/2011

CNRT

SU - NON-FINAL ACTION - WRITTEN

10/25/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/03/2011

IUAF

USE AMENDMENT FILED

09/28/2011

EISU

TEAS STATEMENT OF USE RECEIVED

09/28/2011

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/02/2011

EX1G

SOU EXTENSION 1 GRANTED

04/01/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/31/2011

EXT1

SOU EXTENSION 1 FILED

03/28/2011

EEXT

SOU TEAS EXTENSION RECEIVED

03/28/2011

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/28/2010

TMBN

TTAB RELEASE CASE TO TRADEMARKS

08/17/2010

OP.T

OPPOSITION TERMINATED NO. 999999

08/17/2010

OP.D

OPPOSITION DISMISSED NO. 999999

08/17/2010

OP.I

OPPOSITION INSTITUTED NO. 999999

02/08/2010

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

09/09/2009

PUBO

PUBLISHED FOR OPPOSITION

08/11/2009

NPUB

NOTICE OF PUBLICATION

07/22/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/03/2009

ALIE

ASSIGNED TO LIE

07/03/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/26/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/26/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/26/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/26/2009

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/27/2008

GNRT

NON-FINAL ACTION E-MAILED

12/27/2008

CNRT

NON-FINAL ACTION WRITTEN

12/27/2008

DOCK

ASSIGNED TO EXAMINER

12/20/2008

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

09/26/2008

NWAP

NEW APPLICATION ENTERED

09/25/2008

Continuous trademark protection

Get notified about every new filing that threatens AVIDAS PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.